Search

everythinglearnresearchcommunity

for

Search:↓

Hormones significantly affect hair and oil gland function in the skin, and more research is needed on skin-related hormone disorders.

Peginterferon alfa-2b and ribavirin therapy for hepatitis C can cause serious side effects, some different from those reported in clinical trials.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

Polycystic ovary syndrome is found in 6.5% of unselected Caucasian women in Spain.

Ovarian function was similar in both treatment groups, but both caused excessive hair growth.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

Chemotherapy significantly lowers Inhibin A levels in breast cancer patients.

More men than women have hair loss, it's often inherited, and it's linked with higher testosterone levels. There's been a rise in female hair loss patients.

Higher thyroid hormone levels may be linked to certain types of polycystic ovary syndrome.

Testosterone levels are not linked to erectile dysfunction in young and middle-aged men with HIV.

Ethnicity affects how polycystic ovary syndrome shows up in women, with white women having higher metabolic risks but less diabetes, and South Asian women showing more androgenic symptoms and being younger at presentation.

PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Treating classic 21-hydroxylase deficiency requires precise glucocorticoid dosing and attention to individual patient needs, with new treatments showing promise.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Different animals have unique versions of the enzyme that changes testosterone into another hormone, which is important for creating effective treatments for prostate and hair loss conditions.

Male rats have more somatostatin neurons than females due to testosterone converting to estrogen during early development.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

Men have worse COVID-19 outcomes than women due to genetic and hormonal differences.

Male rats grow hair faster than females, and certain hormones can slow or slightly increase hair growth, but not significantly beyond natural rates.

Hormones and genetics affect hair growth and patterns, with some changes reversible and others not.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Topical finasteride doesn't reduce DHT levels, hinting at an endocrine role in hair loss.

Endocrine-disrupting chemicals cause irreversible harm to children's development, increasing disease risk.

Men and women experience skin aging differently due to changes in sex hormone levels with age.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

Epigenetic differences affect hair loss in identical Japanese male twins.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Male and female bodies respond differently to stress, influenced by hormones and development stages, with implications for stress-related diseases.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.